MedPath

COLOMBO ILARIA

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study

Completed
Conditions
Covid19
Cancer
First Posted Date
2021-03-16
Last Posted Date
2023-03-23
Lead Sponsor
Ilaria Colombo
Target Recruit Count
177
Registration Number
NCT04800146
Locations
🇨🇭

Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.